Paper56538
Dopamine acetylcholine imbalance in Parkinson's disease. Possible regenerative overgrowth of cholinergic axon terminals.
Spehlmann R and 1 other. Lancet, 1976. Cited by 53 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Dopamine acetylcholine imbalance in Parkinson's disease. Possible regenerative overgrowth of cholinergic axon terminals. Papers, record 56538. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/56538
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Dopamine acetylcholine imbalance in Parkinson's disease. Possible regenerative overgrowth of cholinergic axon terminals.
- PubMed
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Acetylcholine | Major topic |
| Axons | Major topic |
| Dopamine | Major topic |
| Parkinson Disease | Major topic |
| Animals | |
| Humans | |
| Hypertrophy | |
| Interneurons | |
| Nerve Degeneration | |
| Nerve Endings | |
| Nerve Regeneration | |
| Receptors, Cholinergic |
Source PubMed
Cited by25
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 53 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41,169,939 | Acupoint stimulation by microneedle alleviates motor dysfunction through modulating striatal dopamine and choline levels and reducing neuroinflammation in the Parkinson's disease mouse model. | J Tradit Complement Med | 2025 | https://conductscience.org/library/papers/41169939 | PubMed |
| 40,593,919 | Postsynaptic adaptations in direct pathway muscarinic M4-receptor signaling follow the temporal and regional pattern of dopaminergic degeneration. | NPJ Parkinsons Dis | 2025 | https://conductscience.org/library/papers/40593919 | PubMed |
| 39,565,858 | Reduced striatal M4-cholinergic signaling following dopamine loss contributes to parkinsonian and l-DOPA-induced dyskinetic behaviors. | Sci Adv | 2024 | https://conductscience.org/library/papers/39565858 | PubMed |
| 39,556,446 | Modulating the cholinergic system-Novel targets for deep brain stimulation in Parkinson's disease. | J Neurochem | 2025 | https://conductscience.org/library/papers/39556446 | PubMed |
| 39,174,646 | The PM20D1-NADA pathway protects against Parkinson's disease. | Cell Death Differ | 2024 | https://conductscience.org/library/papers/39174646 | PubMed |
| 38,573,414 | Unraveling Dysregulated Cell Signaling Pathways, Genetic and Epigenetic Mysteries of Parkinson's Disease. | Mol Neurobiol | 2024 | https://conductscience.org/library/papers/38573414 | PubMed |
| 38,286,464 | Ribose-cysteine and levodopa abrogate Parkinsonism via the regulation of neurochemical and redox activities in alpha-synuclein transgenic Drosophila melanogaster models. | Fly (Austin) | 2024 | https://conductscience.org/library/papers/38286464 | PubMed |
| 38,251,226 | Exploring the Central Mechanisms of Botulinum Toxin in Parkinson's Disease: A Systematic Review from Animal Models to Human Evidence. | Toxins (Basel) | 2023 | https://conductscience.org/library/papers/38251226 | PubMed |
| 37,998,387 | The Neuropharmacological Evaluation of Seaweed: A Potential Therapeutic Source. | Cells | 2023 | https://conductscience.org/library/papers/37998387 | PubMed |
| 35,199,307 | Cytokines, miRNAs, and Antioxidants as Combined Non-invasive Biomarkers for Parkinson's Disease. | J Mol Neurosci | 2022 | https://conductscience.org/library/papers/35199307 | PubMed |
| 34,973,120 | Cholinergic relevant functional reactivity is associated with dopamine responsiveness of tremor in Parkinson's disease. | Brain Imaging Behav | 2022 | https://conductscience.org/library/papers/34973120 | PubMed |
| 34,527,420 | Extracellular Vesicles for the Diagnosis and Treatment of Parkinson's Disease. | Aging Dis | 2021 | https://conductscience.org/library/papers/34527420 | PubMed |
| 34,122,043 | Decreased Exosomal Acetylcholinesterase Activity in the Plasma of Patients With Parkinson's Disease. | Front Aging Neurosci | 2021 | https://conductscience.org/library/papers/34122043 | PubMed |
| 33,255,421 | Propranolol Relieves L-Dopa-Induced Dyskinesia in Parkinsonian Mice. | Brain Sci | 2020 | https://conductscience.org/library/papers/33255421 | PubMed |
| 31,653,548 | Localising movement disorders in childhood. | Lancet Child Adolesc Health | 2019 | https://conductscience.org/library/papers/31653548 | PubMed |
| 31,324,539 | Dopamine Deficiency Reduces Striatal Cholinergic Interneuron Function in Models of Parkinson's Disease. | Neuron | 2019 | https://conductscience.org/library/papers/31324539 | PubMed |
| 31,076,875 | Real-world pharmacological treatment patterns of patients with young-onset Parkinson's disease in Japan: a medical claims database analysis. | J Neurol | 2019 | https://conductscience.org/library/papers/31076875 | PubMed |
| 30,147,647 | Acetylcholine Neurotransmitter Receptor Densities in the Striatum of Hemiparkinsonian Rats Following Botulinum Neurotoxin-A Injection. | Front Neuroanat | 2018 | https://conductscience.org/library/papers/30147647 | PubMed |
| 28,904,985 | Cholinergic activity and levodopa-induced dyskinesia: a multitracer molecular imaging study. | Ann Clin Transl Neurol | 2017 | https://conductscience.org/library/papers/28904985 | PubMed |
| 26,136,679 | A network model of basal ganglia for understanding the roles of dopamine and serotonin in reward-punishment-risk based decision making. | Front Comput Neurosci | 2015 | https://conductscience.org/library/papers/26136679 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/56538
GET https://conductscience.org/api/papers/v1/56538/cited_by?page=2